Pasithea Therapeutics Corp Live Stock Price Today, Share Analysis and Chart

Name: Pasithea Therapeutics Corp: Is Infosys Ltd. worth buying?
Item: Pasithea Therapeutics Corp
Rating: 1.06558325
Author: Trendlyne DVM scores

about

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in ...

0.73 -0.01 (-1.35%)

90.27% Fall from 52W High

92,798

XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.3 / 100

Technically Bearish

27.3 / 100

No estimates available

Pasithea Therapeutics Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pasithea Therapeutics Corp Live Stock Price Today, Share Analysis and Chart

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in ...

90.27% Fall from 52W High

SWOT Analysis

Pasithea Therapeutics Corp Live Price Chart